BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34907282)

  • 61. Identification of chromosomal aberrations of metastatic potential in colorectal carcinoma.
    Yamamoto S; Midorikawa Y; Morikawa T; Nishimura Y; Sakamoto H; Ishikawa S; Akagi K; Aburatani H
    Genes Chromosomes Cancer; 2010 May; 49(5):487-96. PubMed ID: 20175194
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level.
    Macartney-Coxson DP; Hood KA; Shi HJ; Ward T; Wiles A; O'Connor R; Hall DA; Lea RA; Royds JA; Stubbs RS; Rooker S
    BMC Cancer; 2008 Jul; 8():187. PubMed ID: 18590575
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Identification of hub genes, key miRNAs and potential molecular mechanisms of colorectal cancer.
    Wu S; Wu F; Jiang Z
    Oncol Rep; 2017 Oct; 38(4):2043-2050. PubMed ID: 28902367
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Involvement of chemokine receptor CCR6 in colorectal cancer metastasis.
    Rubie C; Oliveira V; Kempf K; Wagner M; Tilton B; Rau B; Kruse B; Konig J; Schilling M
    Tumour Biol; 2006; 27(3):166-74. PubMed ID: 16641550
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Identification of EGFR as a Novel Key Gene in Clear Cell Renal Cell Carcinoma (ccRCC) through Bioinformatics Analysis and Meta-Analysis.
    Wang S; Yu ZH; Chai KQ
    Biomed Res Int; 2019; 2019():6480865. PubMed ID: 30895194
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Identification of Hepatocellular Carcinoma-Related Potential Genes and Pathways Through Bioinformatic-Based Analyses.
    Wan Z; Zhang X; Luo Y; Zhao B
    Genet Test Mol Biomarkers; 2019 Nov; 23(11):766-777. PubMed ID: 31633428
    [No Abstract]   [Full Text] [Related]  

  • 67. Identification of Key Biomarkers and Potential Molecular Mechanisms in Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
    Yang B; Dong K; Guo P; Guo P; Jie G; Zhang G; Li T
    J Comput Biol; 2020 Jan; 27(1):40-54. PubMed ID: 31424263
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Analysis of potential key genes in very early hepatocellular carcinoma.
    Wu M; Liu Z; Li X; Zhang A; Lin D; Li N
    World J Surg Oncol; 2019 May; 17(1):77. PubMed ID: 31043166
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Genome-wide analysis of long noncoding RNA (lncRNA) expression in colorectal cancer tissues from patients with liver metastasis.
    Chen D; Sun Q; Cheng X; Zhang L; Song W; Zhou D; Lin J; Wang W
    Cancer Med; 2016 Jul; 5(7):1629-39. PubMed ID: 27165481
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Identification of Potentially Therapeutic Target Genes of Hepatocellular Carcinoma.
    Li C; Xu J
    Int J Environ Res Public Health; 2020 Feb; 17(3):. PubMed ID: 32046048
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Identification of genes involved in the four stages of colorectal cancer: Gene expression profiling.
    Shi G; Wang Y; Zhang C; Zhao Z; Sun X; Zhang S; Fan J; Zhou C; Zhang J; Zhang H; Liu J
    Mol Cell Probes; 2018 Feb; 37():39-47. PubMed ID: 29179987
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Identification and prediction of novel non-coding and coding RNA-associated competing endogenous RNA networks in colorectal cancer.
    Liang Y; Zhang C; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Dec; 24(46):5259-5270. PubMed ID: 30581274
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Identification of four novel prognosis biomarkers and potential therapeutic drugs for human colorectal cancer by bioinformatics analysis.
    Sun Z; Liu C; Cheng SY
    J Biomed Res; 2020 Oct; 35(1):21-35. PubMed ID: 33361643
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Identification and Interaction Analysis of Molecular Markers in Colorectal Cancer by Integrated Bioinformatics Analysis.
    Han B; Feng D; Yu X; Zhang Y; Liu Y; Zhou L
    Med Sci Monit; 2018 Aug; 24():6059-6069. PubMed ID: 30168505
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker.
    Lin AY; Chua MS; Choi YL; Yeh W; Kim YH; Azzi R; Adams GA; Sainani K; van de Rijn M; So SK; Pollack JR
    PLoS One; 2011 Feb; 6(2):e16636. PubMed ID: 21383983
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Aberrant expression of long noncoding RNA SNHG15 correlates with liver metastasis and poor survival in colorectal cancer.
    Huang L; Lin H; Kang L; Huang P; Huang J; Cai J; Xian Z; Zhu P; Huang M; Wang L; Xian CJ; Wang J; Dong J
    J Cell Physiol; 2019 May; 234(5):7032-7039. PubMed ID: 30317592
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification of an MiRNA-mRNA Regulatory Network in Colorectal Cancer.
    Cui MF; Wu YY; Chen MY; Zhao Y; Han SY; Wang RJ; Zhang H; Fang XD
    Comb Chem High Throughput Screen; 2021; 24(10):1736-1745. PubMed ID: 33172374
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Identification of natural antisense transcripts involved in human colorectal cancer development.
    Kohno K; Chiba M; Murata S; Pak S; Nagai K; Yamamoto M; Yanagisawa K; Kobayashi A; Yasue H; Ohkohchi N
    Int J Oncol; 2010 Dec; 37(6):1425-32. PubMed ID: 21042710
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Significant overexpression of DVL1 in Taiwanese colorectal cancer patients with liver metastasis.
    Huang MY; Yen LC; Liu HC; Liu PP; Chung FY; Wang TN; Wang JY; Lin SR
    Int J Mol Sci; 2013 Oct; 14(10):20492-507. PubMed ID: 24129181
    [TBL] [Abstract][Full Text] [Related]  

  • 80. CREB5 promotes invasiveness and metastasis in colorectal cancer by directly activating MET.
    Wang S; Qiu J; Liu L; Su C; Qi L; Huang C; Chen X; Zhang Y; Ye Y; Ding Y; Liang L; Liao W
    J Exp Clin Cancer Res; 2020 Aug; 39(1):168. PubMed ID: 32843066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.